Polyunsaturated fatty acids-induced ferroptosis suppresses pancreatic cancer growth

Despite recent advances in science and medical technology, pancreatic cancer remains associated with high mortality rates due to aggressive growth and no early clinical sign as well as the unique resistance to anti-cancer chemotherapy. Current numerous investigations have suggested that ferroptosis,...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 14; no. 1; pp. 4409 - 16
Main Authors Suda, Akane, Umaru, Banlanjo Abdulaziz, Yamamoto, Yui, Shima, Hiroki, Saiki, Yuriko, Pan, Yijun, Jin, Liang, Sun, Jiaqi, Low, Yi Ling Clare, Suzuki, Chitose, Abe, Takaaki, Igarashi, Kazuhiko, Furukawa, Toru, Owada, Yuji, Kagawa, Yoshiteru
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 22.02.2024
Nature Publishing Group
Nature Portfolio
Subjects
631/337
631/67
631/80
692/4028
Adenocarcinoma
Cell death
Cell proliferation
Chemotherapy
Drug resistance
Ferroptosis
Gemcitabine
Humanities and Social Sciences
Linoleic acid
Linolenic acid
Lipid peroxidation
Medical technology
multidisciplinary
Pancreatic cancer
Peroxidation
Phosphorylation
Poly unsaturated fatty acids
Polyunsaturated fatty acids
Science
Science (multidisciplinary)
Survival
Tumor cell lines
Tumors
α-Linolenic acid
Ferroptosis
Drug resistance
α-Linolenic acid
Pancreatic cancer
Poly unsaturated fatty acids
Linoleic acid
Online AccessGet full text

Cover

Abstract Despite recent advances in science and medical technology, pancreatic cancer remains associated with high mortality rates due to aggressive growth and no early clinical sign as well as the unique resistance to anti-cancer chemotherapy. Current numerous investigations have suggested that ferroptosis, which is a programed cell death driven by lipid oxidation, is an attractive therapeutic in different tumor types including pancreatic cancer. Here, we first demonstrated that linoleic acid (LA) and α-linolenic acid (αLA) induced cell death with necroptotic morphological change in MIA-Paca2 and Suit 2 cell lines. LA and αLA increased lipid peroxidation and phosphorylation of RIP3 and MLKL in pancreatic cancers, which were negated by ferroptosis inhibitor, ferrostatin-1, restoring back to BSA control levels. Similarly, intraperitoneal administration of LA and αLA suppresses the growth of subcutaneously transplanted Suit-2 cells and ameliorated the decreased survival rate of tumor bearing mice, while co-administration of ferrostatin-1 with LA and αLA negated the anti-cancer effect. We also demonstrated that LA and αLA partially showed ferroptotic effects on the gemcitabine-resistant-PK cells, although its effect was exerted late compared to treatment on normal-PK cells. In addition, the trial to validate the importance of double bonds in PUFAs in ferroptosis revealed that AA and EPA had a marked effect of ferroptosis on pancreatic cancer cells, but DHA showed mild suppression of cancer proliferation. Furthermore, treatment in other tumor cell lines revealed different sensitivity of PUFA-induced ferroptosis; e.g., EPA induced a ferroptotic effect on colorectal adenocarcinoma, but LA or αLA did not. Collectively, these data suggest that PUFAs can have a potential to exert an anti-cancer effect via ferroptosis in both normal and gemcitabine-resistant pancreatic cancer.
AbstractList Despite recent advances in science and medical technology, pancreatic cancer remains associated with high mortality rates due to aggressive growth and no early clinical sign as well as the unique resistance to anti-cancer chemotherapy. Current numerous investigations have suggested that ferroptosis, which is a programed cell death driven by lipid oxidation, is an attractive therapeutic in different tumor types including pancreatic cancer. Here, we first demonstrated that linoleic acid (LA) and α-linolenic acid (αLA) induced cell death with necroptotic morphological change in MIA-Paca2 and Suit 2 cell lines. LA and αLA increased lipid peroxidation and phosphorylation of RIP3 and MLKL in pancreatic cancers, which were negated by ferroptosis inhibitor, ferrostatin-1, restoring back to BSA control levels. Similarly, intraperitoneal administration of LA and αLA suppresses the growth of subcutaneously transplanted Suit-2 cells and ameliorated the decreased survival rate of tumor bearing mice, while co-administration of ferrostatin-1 with LA and αLA negated the anti-cancer effect. We also demonstrated that LA and αLA partially showed ferroptotic effects on the gemcitabine-resistant-PK cells, although its effect was exerted late compared to treatment on normal-PK cells. In addition, the trial to validate the importance of double bonds in PUFAs in ferroptosis revealed that AA and EPA had a marked effect of ferroptosis on pancreatic cancer cells, but DHA showed mild suppression of cancer proliferation. Furthermore, treatment in other tumor cell lines revealed different sensitivity of PUFA-induced ferroptosis; e.g., EPA induced a ferroptotic effect on colorectal adenocarcinoma, but LA or αLA did not. Collectively, these data suggest that PUFAs can have a potential to exert an anti-cancer effect via ferroptosis in both normal and gemcitabine-resistant pancreatic cancer.Despite recent advances in science and medical technology, pancreatic cancer remains associated with high mortality rates due to aggressive growth and no early clinical sign as well as the unique resistance to anti-cancer chemotherapy. Current numerous investigations have suggested that ferroptosis, which is a programed cell death driven by lipid oxidation, is an attractive therapeutic in different tumor types including pancreatic cancer. Here, we first demonstrated that linoleic acid (LA) and α-linolenic acid (αLA) induced cell death with necroptotic morphological change in MIA-Paca2 and Suit 2 cell lines. LA and αLA increased lipid peroxidation and phosphorylation of RIP3 and MLKL in pancreatic cancers, which were negated by ferroptosis inhibitor, ferrostatin-1, restoring back to BSA control levels. Similarly, intraperitoneal administration of LA and αLA suppresses the growth of subcutaneously transplanted Suit-2 cells and ameliorated the decreased survival rate of tumor bearing mice, while co-administration of ferrostatin-1 with LA and αLA negated the anti-cancer effect. We also demonstrated that LA and αLA partially showed ferroptotic effects on the gemcitabine-resistant-PK cells, although its effect was exerted late compared to treatment on normal-PK cells. In addition, the trial to validate the importance of double bonds in PUFAs in ferroptosis revealed that AA and EPA had a marked effect of ferroptosis on pancreatic cancer cells, but DHA showed mild suppression of cancer proliferation. Furthermore, treatment in other tumor cell lines revealed different sensitivity of PUFA-induced ferroptosis; e.g., EPA induced a ferroptotic effect on colorectal adenocarcinoma, but LA or αLA did not. Collectively, these data suggest that PUFAs can have a potential to exert an anti-cancer effect via ferroptosis in both normal and gemcitabine-resistant pancreatic cancer.
Despite recent advances in science and medical technology, pancreatic cancer remains associated with high mortality rates due to aggressive growth and no early clinical sign as well as the unique resistance to anti-cancer chemotherapy. Current numerous investigations have suggested that ferroptosis, which is a programed cell death driven by lipid oxidation, is an attractive therapeutic in different tumor types including pancreatic cancer. Here, we first demonstrated that linoleic acid (LA) and α-linolenic acid (αLA) induced cell death with necroptotic morphological change in MIA-Paca2 and Suit 2 cell lines. LA and αLA increased lipid peroxidation and phosphorylation of RIP3 and MLKL in pancreatic cancers, which were negated by ferroptosis inhibitor, ferrostatin-1, restoring back to BSA control levels. Similarly, intraperitoneal administration of LA and αLA suppresses the growth of subcutaneously transplanted Suit-2 cells and ameliorated the decreased survival rate of tumor bearing mice, while co-administration of ferrostatin-1 with LA and αLA negated the anti-cancer effect. We also demonstrated that LA and αLA partially showed ferroptotic effects on the gemcitabine-resistant-PK cells, although its effect was exerted late compared to treatment on normal-PK cells. In addition, the trial to validate the importance of double bonds in PUFAs in ferroptosis revealed that AA and EPA had a marked effect of ferroptosis on pancreatic cancer cells, but DHA showed mild suppression of cancer proliferation. Furthermore, treatment in other tumor cell lines revealed different sensitivity of PUFA-induced ferroptosis; e.g., EPA induced a ferroptotic effect on colorectal adenocarcinoma, but LA or αLA did not. Collectively, these data suggest that PUFAs can have a potential to exert an anti-cancer effect via ferroptosis in both normal and gemcitabine-resistant pancreatic cancer.
Abstract Despite recent advances in science and medical technology, pancreatic cancer remains associated with high mortality rates due to aggressive growth and no early clinical sign as well as the unique resistance to anti-cancer chemotherapy. Current numerous investigations have suggested that ferroptosis, which is a programed cell death driven by lipid oxidation, is an attractive therapeutic in different tumor types including pancreatic cancer. Here, we first demonstrated that linoleic acid (LA) and α-linolenic acid (αLA) induced cell death with necroptotic morphological change in MIA-Paca2 and Suit 2 cell lines. LA and αLA increased lipid peroxidation and phosphorylation of RIP3 and MLKL in pancreatic cancers, which were negated by ferroptosis inhibitor, ferrostatin-1, restoring back to BSA control levels. Similarly, intraperitoneal administration of LA and αLA suppresses the growth of subcutaneously transplanted Suit-2 cells and ameliorated the decreased survival rate of tumor bearing mice, while co-administration of ferrostatin-1 with LA and αLA negated the anti-cancer effect. We also demonstrated that LA and αLA partially showed ferroptotic effects on the gemcitabine-resistant-PK cells, although its effect was exerted late compared to treatment on normal-PK cells. In addition, the trial to validate the importance of double bonds in PUFAs in ferroptosis revealed that AA and EPA had a marked effect of ferroptosis on pancreatic cancer cells, but DHA showed mild suppression of cancer proliferation. Furthermore, treatment in other tumor cell lines revealed different sensitivity of PUFA-induced ferroptosis; e.g., EPA induced a ferroptotic effect on colorectal adenocarcinoma, but LA or αLA did not. Collectively, these data suggest that PUFAs can have a potential to exert an anti-cancer effect via ferroptosis in both normal and gemcitabine-resistant pancreatic cancer.
Despite recent advances in science and medical technology, pancreatic cancer remains associated with high mortality rates due to aggressive growth and no early clinical sign as well as the unique resistance to anti-cancer chemotherapy. Current numerous investigations have suggested that ferroptosis, which is a programed cell death driven by lipid oxidation, is an attractive therapeutic in different tumor types including pancreatic cancer. Here, we first demonstrated that linoleic acid (LA) and α-linolenic acid (αLA) induced cell death with necroptotic morphological change in MIA-Paca2 and Suit 2 cell lines. LA and αLA increased lipid peroxidation and phosphorylation of RIP3 and MLKL in pancreatic cancers, which were negated by ferroptosis inhibitor, ferrostatin-1, restoring back to BSA control levels. Similarly, intraperitoneal administration of LA and αLA suppresses the growth of subcutaneously transplanted Suit-2 cells and ameliorated the decreased survival rate of tumor bearing mice, while co-administration of ferrostatin-1 with LA and αLA negated the anti-cancer effect. We also demonstrated that LA and αLA partially showed ferroptotic effects on the gemcitabine-resistant-PK cells, although its effect was exerted late compared to treatment on normal-PK cells. In addition, the trial to validate the importance of double bonds in PUFAs in ferroptosis revealed that AA and EPA had a marked effect of ferroptosis on pancreatic cancer cells, but DHA showed mild suppression of cancer proliferation. Furthermore, treatment in other tumor cell lines revealed different sensitivity of PUFA-induced ferroptosis; e.g., EPA induced a ferroptotic effect on colorectal adenocarcinoma, but LA or αLA did not. Collectively, these data suggest that PUFAs can have a potential to exert an anti-cancer effect via ferroptosis in both normal and gemcitabine-resistant pancreatic cancer.
ArticleNumber 4409
Author Jin, Liang
Shima, Hiroki
Pan, Yijun
Abe, Takaaki
Suda, Akane
Yamamoto, Yui
Igarashi, Kazuhiko
Sun, Jiaqi
Furukawa, Toru
Saiki, Yuriko
Suzuki, Chitose
Kagawa, Yoshiteru
Owada, Yuji
Umaru, Banlanjo Abdulaziz
Low, Yi Ling Clare
Author_xml – sequence: 1
  givenname: Akane
  surname: Suda
  fullname: Suda, Akane
  organization: Florey Institute of Neuroscience and Mental Health, University of Melbourne, Department of Organ Anatomy, Graduate School of Medicine, Tohoku University
– sequence: 2
  givenname: Banlanjo Abdulaziz
  surname: Umaru
  fullname: Umaru, Banlanjo Abdulaziz
  organization: Department of Organ Anatomy, Graduate School of Medicine, Tohoku University, Center for Childhood Cancer Research, Nationwide Children’s Hospital
– sequence: 3
  givenname: Yui
  surname: Yamamoto
  fullname: Yamamoto, Yui
  organization: Department of Organ Anatomy, Graduate School of Medicine, Tohoku University
– sequence: 4
  givenname: Hiroki
  surname: Shima
  fullname: Shima, Hiroki
  organization: Department of Biochemistry, Tohoku University Graduate School of Medicine
– sequence: 5
  givenname: Yuriko
  surname: Saiki
  fullname: Saiki, Yuriko
  organization: Department of Investigative Pathology, Tohoku University Graduate School of Medicine
– sequence: 6
  givenname: Yijun
  surname: Pan
  fullname: Pan, Yijun
  organization: Florey Institute of Neuroscience and Mental Health, University of Melbourne, Department of Organ Anatomy, Graduate School of Medicine, Tohoku University, Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University
– sequence: 7
  givenname: Liang
  surname: Jin
  fullname: Jin, Liang
  organization: Florey Institute of Neuroscience and Mental Health, University of Melbourne, Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University
– sequence: 8
  givenname: Jiaqi
  surname: Sun
  fullname: Sun, Jiaqi
  organization: Florey Institute of Neuroscience and Mental Health, University of Melbourne
– sequence: 9
  givenname: Yi Ling Clare
  surname: Low
  fullname: Low, Yi Ling Clare
  organization: Florey Institute of Neuroscience and Mental Health, University of Melbourne
– sequence: 10
  givenname: Chitose
  surname: Suzuki
  fullname: Suzuki, Chitose
  organization: Department of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 11
  givenname: Takaaki
  surname: Abe
  fullname: Abe, Takaaki
  organization: Department of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine
– sequence: 12
  givenname: Kazuhiko
  surname: Igarashi
  fullname: Igarashi, Kazuhiko
  organization: Department of Biochemistry, Tohoku University Graduate School of Medicine
– sequence: 13
  givenname: Toru
  surname: Furukawa
  fullname: Furukawa, Toru
  organization: Department of Investigative Pathology, Tohoku University Graduate School of Medicine
– sequence: 14
  givenname: Yuji
  surname: Owada
  fullname: Owada, Yuji
  organization: Department of Organ Anatomy, Graduate School of Medicine, Tohoku University
– sequence: 15
  givenname: Yoshiteru
  surname: Kagawa
  fullname: Kagawa, Yoshiteru
  email: yoshiteru.kagawa@florey.edu.au
  organization: Florey Institute of Neuroscience and Mental Health, University of Melbourne, Department of Organ Anatomy, Graduate School of Medicine, Tohoku University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38388563$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1rFTEUhoNUbK39Ay5kwI2b0XzOJEspVgsFBdt1yCQn11zmTsYkg9x_39w7tUoXzSI5HJ73fOR9jU6mOAFCbwn-SDCTnzInQskWU94KgQVu-Qt0RjEXLWWUnvwXn6KLnLe4HkEVJ-oVOmWSSSk6doZ-_ojjfpmyKUsyBVzjTSn7xtjgchsmt9hDDlKKc4k55CYv85wgZ8jNbCabwJRgG1tDSM0mxT_l1xv00psxw8XDe47urr7cXn5rb75_vb78fNNaIUhpB6a8IpwR02FLKB-wr7cgtJcDsRSAdo6DxbwD17EOG-Z65hn3gyMcKGbn6Hqt66LZ6jmFnUl7HU3Qx0RMG21SnW4EPWAiPbcd9GrgkoLk1HHha2-hlBOHWh_WWnOKvxfIRe9CtjCOZoK4ZE0Vo5j0uKcVff8E3cYlTXXTA4UZF-pIvXuglmEH7nG8v19fAboCNsWcE_hHhGB9sFivFutqsT5arHkVySciG0p1IE4lmTA-L2WrNNc-0wbSv7GfUd0DpCC5KQ
CitedBy_id crossref_primary_10_1016_j_tips_2024_04_007
crossref_primary_10_1039_D4FO05606J
crossref_primary_10_1093_carcin_bgae081
crossref_primary_10_1080_07853890_2024_2445774
crossref_primary_10_3390_nu16111737
crossref_primary_10_1016_j_jlr_2025_100765
crossref_primary_10_1038_s41419_024_07150_2
crossref_primary_10_1002_lipd_12420
crossref_primary_10_1016_j_jlr_2024_100657
crossref_primary_10_3390_toxics12070493
Cites_doi 10.1007/s12035-020-02057-3
10.1016/S0140-6736(16)00141-0
10.1074/jbc.M113.484576
10.1038/s41580-020-00324-8
10.1111/febs.16672
10.1016/j.ccell.2022.02.003
10.1016/j.chembiol.2021.01.006
10.1016/j.bbrc.2012.03.122
10.1529/biophysj.107.112565
10.1194/jlr.R120000800
10.1016/j.freeradbiomed.2018.09.014
10.1038/s41420-022-01212-0
10.1016/j.cell.2013.12.010
10.1016/j.cmet.2021.05.016
10.1038/nature24297
10.1042/BST20160474
10.1186/s13045-019-0720-y
10.1016/j.clinthera.2017.08.015
10.1038/s41419-023-05930-w
10.1038/s41556-019-0305-6
10.1016/j.ebiom.2023.104510
10.1021/acscentsci.7b00028
10.1038/s41556-020-0565-1
10.1371/journal.pmed.1000267
10.1016/j.plipres.2019.101017
10.5114/aoms.2015.54865
10.1152/physrev.00003.2009
10.1016/bs.pmbts.2016.09.008
10.1620/tjem.150.231
10.21873/anticanres.16079
10.1016/j.cell.2017.09.021
10.1194/jlr.M200356-JLR200
10.1016/j.redox.2022.102546
10.1056/NEJMoa1011923
10.1038/nchembio.2238
10.1016/j.redox.2023.102840
10.1093/jmcb/mjaa055
10.1016/j.bbrc.2016.10.086
10.1007/s11095-021-03009-9
10.1038/s41418-022-01096-8
10.1016/S1470-2045(16)00172-8
10.1073/pnas.2006828117
10.1016/j.cell.2009.05.021
10.3945/jn.111.149328
10.7314/apjcp.2015.16.14.5619
10.1016/s1388-1981(99)00137-7
10.1016/j.chembiol.2018.11.016
10.1111/cas.14181
10.1620/tjem.143.33
10.1038/s41586-019-1705-2
10.3390/molecules27051677
10.1038/sj.onc.1206952
10.1007/s12017-008-8036-z
10.1038/s41575-018-0005-x
10.1038/s41423-020-00630-3
10.1074/jbc.M112.415729
10.1038/nchembio.2239
10.1038/s41586-020-2732-8
10.1186/1741-7015-10-50
10.1038/s41571-020-00462-0
10.1016/j.cmet.2020.06.002
10.1016/j.devcel.2021.04.013
10.1016/j.bbalip.2017.12.006
10.1021/ja411006a
10.1038/nature23007
10.1038/s41419-019-1984-4
10.1056/NEJMoa1304369
10.1158/1535-7163.MCT-09-0551
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOA
DOI 10.1038/s41598-024-55050-4
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Publicly Available Content Database

CrossRef

PubMed
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 16
ExternalDocumentID oai_doaj_org_article_b018f4c6e79b482e842d45f31a599d50
38388563
10_1038_s41598_024_55050_4
Genre Journal Article
GrantInformation_xml – fundername: Japan Society for the Promotion of Science
  grantid: 20KK0225; 20K11527
  funderid: http://dx.doi.org/10.13039/501100001691
– fundername: Takeda Science Foundation
  funderid: http://dx.doi.org/10.13039/100007449
– fundername: Japan Society for the Promotion of Science
  grantid: 20KK0225
– fundername: Japan Society for the Promotion of Science
  grantid: 20K11527
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
NPM
PJZUB
PPXIY
PQGLB
7XB
8FK
AARCD
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
ID FETCH-LOGICAL-c551t-b39f91431a60c124b0f12451278b1c2ee26d4ec046ed6360a3d73f34fbd14e203
IEDL.DBID 7X7
ISSN 2045-2322
IngestDate Wed Aug 27 01:30:06 EDT 2025
Mon Jul 21 09:23:50 EDT 2025
Wed Aug 13 04:10:57 EDT 2025
Mon Jul 21 05:51:00 EDT 2025
Tue Jul 01 00:51:27 EDT 2025
Thu Apr 24 23:00:25 EDT 2025
Fri Feb 21 02:37:58 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Ferroptosis
Drug resistance
α-Linolenic acid
Pancreatic cancer
Poly unsaturated fatty acids
Linoleic acid
Language English
License 2024. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c551t-b39f91431a60c124b0f12451278b1c2ee26d4ec046ed6360a3d73f34fbd14e203
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2930345972?pq-origsite=%requestingapplication%
PMID 38388563
PQID 2930345972
PQPubID 2041939
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_b018f4c6e79b482e842d45f31a599d50
proquest_miscellaneous_2932017072
proquest_journals_2930345972
pubmed_primary_38388563
crossref_primary_10_1038_s41598_024_55050_4
crossref_citationtrail_10_1038_s41598_024_55050_4
springer_journals_10_1038_s41598_024_55050_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-02-22
PublicationDateYYYYMMDD 2024-02-22
PublicationDate_xml – month: 02
  year: 2024
  text: 2024-02-22
  day: 22
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2024
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Yang (CR18) 2014; 156
Von Hoff (CR7) 2013; 369
Chen (CR31) 2023; 14
Muller (CR15) 2022
Saiki (CR34) 2012; 421
Kagawa (CR72) 2020; 57
Riegman (CR9) 2020; 22
Lim (CR20) 2013; 288
Ma (CR41) 2022; 8
Wang (CR68) 2019; 10
Lim, Han, Dai, Shen, Wu (CR35) 2009; 8
Kobari, Matsuno, Sato, Kan, Tachibana (CR71) 1984; 143
Dyall, Michael-Titus (CR63) 2008; 10
de Lorgeril, Salen (CR64) 2012; 10
Chu (CR40) 2019; 21
Damaraju (CR52) 2003; 22
Cheng (CR56) 2020; 32
Kagan (CR28) 2017; 13
Conroy (CR6) 2011; 364
Mou (CR13) 2019; 12
Tong (CR38) 2023; 65
Zilka (CR47) 2017; 3
Else (CR23) 2020; 77
Chen, Kang, Kroemer, Tang (CR36) 2021; 18
Glatz, Luiken, Bonen (CR62) 2010; 90
Doll (CR27) 2017; 13
Abumrad, Coburn, Ibrahimi (CR61) 1999; 1441
Arora (CR54) 2013; 288
Bersuker (CR12) 2019; 575
Dierge (CR60) 2021; 33
Gillen, Schuster, MeyerZumBuschenfelde, Friess, Kleeff (CR4) 2010; 7
Kuang, Liu, Xie, Tang, Kang (CR50) 2021; 28
Haycock (CR42) 2023; 91
Broadfield, Pane, Talebi, Swinnen, Fendt (CR44) 2021; 56
Wong-Ekkabut (CR46) 2007; 93
Seibt, Proneth, Conrad (CR11) 2019; 133
Ng, Tsao, Chow, Hedley (CR53) 2000; 60
Lee (CR66) 2020; 117
Harayama, Shimizu (CR22) 2020; 61
Calder (CR24) 2017; 45
Neoptolemos (CR51) 2018; 15
Yu (CR19) 2019; 110
Hangauer (CR17) 2017; 551
Zhang (CR43) 2015; 11
He (CR33) 2009; 137
Skouta (CR48) 2014; 136
Gaschler, Stockwell (CR45) 2017; 482
Yang (CR55) 2011; 2
Jarc (CR57) 1863; 247–265
Jarc, Petan (CR58) 2019; 92
Grant, Hua, Singh (CR3) 2016; 144
Liao (CR65) 2022; 40
Funari, Barcelo, Escriba (CR21) 2003; 44
Ye (CR49) 2020; 10
Sugezawa (CR14) 2022; 42
Bertheloot, Latz, Franklin (CR30) 2021; 18
Yuan (CR16) 2022; 58
Magtanong (CR29) 2019; 26
Kamisawa, Wood, Itoi, Takaori (CR1) 2016; 388
Stockwell (CR37) 2017; 171
Ferreira, Falcato, Bandarra, Rauter (CR25) 2022; 27
Umaru (CR59) 2023; 290
Goral (CR2) 2015; 16
Saung, Zheng (CR8) 2017; 39
Kobari (CR70) 1986; 150
Li, Tong, Zhang, Wei, Wei (CR32) 2021; 13
Decker, Akoh, Wilkes (CR26) 2012; 142
Viswanathan (CR67) 2017; 547
Zou (CR39) 2020; 585
Umaru (CR69) 2021; 38
Suker (CR5) 2016; 17
Jiang, Stockwell, Conrad (CR10) 2021; 22
T Conroy (55050_CR6) 2011; 364
M Kobari (55050_CR70) 1986; 150
TJ Grant (55050_CR3) 2016; 144
Y Zou (55050_CR39) 2020; 585
Z Chen (55050_CR31) 2023; 14
Y Saiki (55050_CR34) 2012; 421
D Bertheloot (55050_CR30) 2021; 18
VL Damaraju (55050_CR52) 2003; 22
X Jiang (55050_CR10) 2021; 22
PC Calder (55050_CR24) 2017; 45
F Kuang (55050_CR50) 2021; 28
Y Yang (55050_CR55) 2011; 2
JP Neoptolemos (55050_CR51) 2018; 15
T Ma (55050_CR41) 2022; 8
O Zilka (55050_CR47) 2017; 3
X Cheng (55050_CR56) 2020; 32
PL Else (55050_CR23) 2020; 77
VE Kagan (55050_CR28) 2017; 13
T Kamisawa (55050_CR1) 2016; 388
L Li (55050_CR32) 2021; 13
K Lim (55050_CR35) 2009; 8
JF Glatz (55050_CR62) 2010; 90
MT Saung (55050_CR8) 2017; 39
T Harayama (55050_CR22) 2020; 61
Y Mou (55050_CR13) 2019; 12
Y Kagawa (55050_CR72) 2020; 57
S Doll (55050_CR27) 2017; 13
V Goral (55050_CR2) 2015; 16
JH Lim (55050_CR20) 2013; 288
L Magtanong (55050_CR29) 2019; 26
PC Haycock (55050_CR42) 2023; 91
BR Stockwell (55050_CR37) 2017; 171
P Liao (55050_CR65) 2022; 40
M Yu (55050_CR19) 2019; 110
JY Lee (55050_CR66) 2020; 117
EA Decker (55050_CR26) 2012; 142
E Jarc (55050_CR58) 2019; 92
J Yuan (55050_CR16) 2022; 58
Y Tong (55050_CR38) 2023; 65
BA Umaru (55050_CR59) 2023; 290
M Riegman (55050_CR9) 2020; 22
LA Broadfield (55050_CR44) 2021; 56
E Dierge (55050_CR60) 2021; 33
K Sugezawa (55050_CR14) 2022; 42
WS Yang (55050_CR18) 2014; 156
SS Funari (55050_CR21) 2003; 44
SSW Ng (55050_CR53) 2000; 60
S He (55050_CR33) 2009; 137
F Muller (55050_CR15) 2022
K Bersuker (55050_CR12) 2019; 575
MJ Hangauer (55050_CR17) 2017; 551
I Ferreira (55050_CR25) 2022; 27
C Zhang (55050_CR43) 2015; 11
MM Gaschler (55050_CR45) 2017; 482
BA Umaru (55050_CR69) 2021; 38
J Wong-Ekkabut (55050_CR46) 2007; 93
DD Von Hoff (55050_CR7) 2013; 369
VS Viswanathan (55050_CR67) 2017; 547
TX Wang (55050_CR68) 2019; 10
M Suker (55050_CR5) 2016; 17
E Jarc (55050_CR57) 1863; 247–265
SC Dyall (55050_CR63) 2008; 10
Z Ye (55050_CR49) 2020; 10
X Chen (55050_CR36) 2021; 18
S Arora (55050_CR54) 2013; 288
M de Lorgeril (55050_CR64) 2012; 10
B Chu (55050_CR40) 2019; 21
R Skouta (55050_CR48) 2014; 136
N Abumrad (55050_CR61) 1999; 1441
TM Seibt (55050_CR11) 2019; 133
S Gillen (55050_CR4) 2010; 7
M Kobari (55050_CR71) 1984; 143
References_xml – volume: 2
  start-page: 89
  year: 2011
  end-page: 98
  ident: CR55
  article-title: Role of fatty acid synthase in gemcitabine and radiation resistance of pancreatic cancers
  publication-title: Int. J. Biochem. Mol. Biol.
– volume: 57
  start-page: 4891
  year: 2020
  end-page: 4910
  ident: CR72
  article-title: FABP7 regulates acetyl-CoA metabolism through the interaction with ACLY in the nucleus of astrocytes
  publication-title: Mol. Neurobiol.
  doi: 10.1007/s12035-020-02057-3
– volume: 388
  start-page: 73
  year: 2016
  end-page: 85
  ident: CR1
  article-title: Pancreatic cancer
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)00141-0
– volume: 288
  start-page: 21197
  year: 2013
  end-page: 21207
  ident: CR54
  article-title: An undesired effect of chemotherapy: Gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor kappaB- and hypoxia-inducible factor 1alpha-mediated up-regulation of CXCR4
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M113.484576
– volume: 22
  start-page: 266
  year: 2021
  end-page: 282
  ident: CR10
  article-title: Ferroptosis: Mechanisms, biology and role in disease
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/s41580-020-00324-8
– volume: 290
  start-page: 1798
  year: 2023
  end-page: 1821
  ident: CR59
  article-title: Oleic acid-bound FABP7 drives glioma cell proliferation through regulation of nuclear lipid droplet formation
  publication-title: FEBS J.
  doi: 10.1111/febs.16672
– volume: 40
  start-page: e366
  issue: 365–378
  year: 2022
  ident: CR65
  article-title: CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2022.02.003
– volume: 28
  start-page: 765
  year: 2021
  end-page: 775
  ident: CR50
  article-title: MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells
  publication-title: Cell Chem. Biol.
  doi: 10.1016/j.chembiol.2021.01.006
– volume: 421
  start-page: 98
  year: 2012
  end-page: 104
  ident: CR34
  article-title: DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2012.03.122
– volume: 93
  start-page: 4225
  year: 2007
  end-page: 4236
  ident: CR46
  article-title: Effect of lipid peroxidation on the properties of lipid bilayers: A molecular dynamics study
  publication-title: Biophys. J.
  doi: 10.1529/biophysj.107.112565
– volume: 61
  start-page: 1150
  year: 2020
  end-page: 1160
  ident: CR22
  article-title: Roles of polyunsaturated fatty acids, from mediators to membranes
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.R120000800
– volume: 133
  start-page: 144
  year: 2019
  end-page: 152
  ident: CR11
  article-title: Role of GPX4 in ferroptosis and its pharmacological implication
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2018.09.014
– volume: 8
  start-page: 434
  year: 2022
  ident: CR41
  article-title: GPX4-independent ferroptosis-a new strategy in disease’s therapy
  publication-title: Cell Death Discov.
  doi: 10.1038/s41420-022-01212-0
– volume: 156
  start-page: 317
  year: 2014
  end-page: 331
  ident: CR18
  article-title: Regulation of ferroptotic cancer cell death by GPX4
  publication-title: Cell
  doi: 10.1016/j.cell.2013.12.010
– volume: 33
  start-page: 1701
  year: 2021
  end-page: 1715
  ident: CR60
  article-title: Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2021.05.016
– volume: 551
  start-page: 247
  year: 2017
  end-page: 250
  ident: CR17
  article-title: Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
  publication-title: Nature
  doi: 10.1038/nature24297
– volume: 45
  start-page: 1105
  year: 2017
  end-page: 1115
  ident: CR24
  article-title: Omega-3 fatty acids and inflammatory processes: From molecules to man
  publication-title: Biochem. Soc. Trans.
  doi: 10.1042/BST20160474
– volume: 12
  start-page: 34
  year: 2019
  ident: CR13
  article-title: Ferroptosis, a new form of cell death: Opportunities and challenges in cancer
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/s13045-019-0720-y
– volume: 39
  start-page: 2125
  year: 2017
  end-page: 2134
  ident: CR8
  article-title: Current standards of chemotherapy for pancreatic cancer
  publication-title: Clin. Ther.
  doi: 10.1016/j.clinthera.2017.08.015
– volume: 14
  start-page: 460
  year: 2023
  ident: CR31
  article-title: Ferroptosis as a potential target for cancer therapy
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-023-05930-w
– volume: 21
  start-page: 579
  year: 2019
  end-page: 591
  ident: CR40
  article-title: ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway
  publication-title: Nat. Cell Biol.
  doi: 10.1038/s41556-019-0305-6
– volume: 91
  start-page: 104510
  year: 2023
  ident: CR42
  article-title: The association between genetically elevated polyunsaturated fatty acids and risk of cancer
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2023.104510
– volume: 3
  start-page: 232
  year: 2017
  end-page: 243
  ident: CR47
  article-title: On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death
  publication-title: ACS Cent. Sci.
  doi: 10.1021/acscentsci.7b00028
– volume: 22
  start-page: 1042
  year: 2020
  end-page: 1048
  ident: CR9
  article-title: Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture
  publication-title: Nat. Cell Biol.
  doi: 10.1038/s41556-020-0565-1
– volume: 7
  start-page: e1000267
  year: 2010
  ident: CR4
  article-title: Preoperative/neoadjuvant therapy in pancreatic cancer: A systematic review and meta-analysis of response and resection percentages
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.1000267
– volume: 77
  start-page: 101017
  year: 2020
  ident: CR23
  article-title: The highly unnatural fatty acid profile of cells in culture
  publication-title: Prog. Lipid Res.
  doi: 10.1016/j.plipres.2019.101017
– volume: 11
  start-page: 1081
  year: 2015
  end-page: 1094
  ident: CR43
  article-title: Polyunsaturated fatty acids trigger apoptosis of colon cancer cells through a mitochondrial pathway
  publication-title: Arch. Med. Sci.
  doi: 10.5114/aoms.2015.54865
– volume: 90
  start-page: 367
  year: 2010
  end-page: 417
  ident: CR62
  article-title: Membrane fatty acid transporters as regulators of lipid metabolism: Implications for metabolic disease
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.00003.2009
– volume: 144
  start-page: 241
  year: 2016
  end-page: 275
  ident: CR3
  article-title: Molecular pathogenesis of pancreatic cancer
  publication-title: Prog. Mol. Biol. Transl. Sci.
  doi: 10.1016/bs.pmbts.2016.09.008
– volume: 150
  start-page: 231
  year: 1986
  end-page: 248
  ident: CR70
  article-title: Establishment of six human pancreatic cancer cell lines and their sensitivities to anti-tumor drugs
  publication-title: Tohoku J. Exp. Med.
  doi: 10.1620/tjem.150.231
– volume: 42
  start-page: 5719
  year: 2022
  end-page: 5729
  ident: CR14
  article-title: GPX4 regulates tumor cell proliferation via suppressing ferroptosis and exhibits prognostic significance in gastric cancer
  publication-title: Anticancer Res.
  doi: 10.21873/anticanres.16079
– volume: 171
  start-page: 273
  year: 2017
  end-page: 285
  ident: CR37
  article-title: Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease
  publication-title: Cell
  doi: 10.1016/j.cell.2017.09.021
– volume: 44
  start-page: 567
  year: 2003
  end-page: 575
  ident: CR21
  article-title: Effects of oleic acid and its congeners, elaidic and stearic acids, on the structural properties of phosphatidylethanolamine membranes
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.M200356-JLR200
– volume: 58
  start-page: 102546
  year: 2022
  ident: CR16
  article-title: HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma
  publication-title: Redox Biol.
  doi: 10.1016/j.redox.2022.102546
– volume: 364
  start-page: 1817
  year: 2011
  end-page: 1825
  ident: CR6
  article-title: FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1011923
– volume: 13
  start-page: 81
  year: 2017
  end-page: 90
  ident: CR28
  article-title: Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.2238
– volume: 65
  start-page: 102840
  year: 2023
  ident: CR38
  article-title: Comparative mechanistic study of RPE cell death induced by different oxidative stresses
  publication-title: Redox Biol.
  doi: 10.1016/j.redox.2023.102840
– volume: 13
  start-page: 3
  year: 2021
  end-page: 14
  ident: CR32
  article-title: The molecular mechanisms of MLKL-dependent and MLKL-independent necrosis
  publication-title: J. Mol. Cell Biol.
  doi: 10.1093/jmcb/mjaa055
– volume: 482
  start-page: 419
  year: 2017
  end-page: 425
  ident: CR45
  article-title: Lipid peroxidation in cell death
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2016.10.086
– volume: 38
  start-page: 479
  year: 2021
  end-page: 490
  ident: CR69
  article-title: Ligand bound fatty acid binding protein 7 (FABP7) drives melanoma cell proliferation via modulation of Wnt/beta-catenin signaling
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-021-03009-9
– year: 2022
  ident: CR15
  article-title: Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation
  publication-title: Cell Death Differ.
  doi: 10.1038/s41418-022-01096-8
– volume: 17
  start-page: 801
  year: 2016
  end-page: 810
  ident: CR5
  article-title: FOLFIRINOX for locally advanced pancreatic cancer: A systematic review and patient-level meta-analysis
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(16)00172-8
– volume: 117
  start-page: 32433
  year: 2020
  end-page: 32442
  ident: CR66
  article-title: Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.2006828117
– volume: 137
  start-page: 1100
  year: 2009
  end-page: 1111
  ident: CR33
  article-title: Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha
  publication-title: Cell
  doi: 10.1016/j.cell.2009.05.021
– volume: 142
  start-page: 610S
  year: 2012
  end-page: 613S
  ident: CR26
  article-title: Incorporation of (n-3) fatty acids in foods: challenges and opportunities
  publication-title: J. Nutr.
  doi: 10.3945/jn.111.149328
– volume: 16
  start-page: 5619
  year: 2015
  end-page: 5624
  ident: CR2
  article-title: Pancreatic cancer: Pathogenesis and diagnosis
  publication-title: Asian Pac. J. Cancer Prev.
  doi: 10.7314/apjcp.2015.16.14.5619
– volume: 1441
  start-page: 4
  year: 1999
  end-page: 13
  ident: CR61
  article-title: Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36 FATP and FABPm
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/s1388-1981(99)00137-7
– volume: 26
  start-page: 420
  year: 2019
  end-page: 432
  ident: CR29
  article-title: Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state
  publication-title: Cell Chem. Biol.
  doi: 10.1016/j.chembiol.2018.11.016
– volume: 110
  start-page: 3173
  year: 2019
  end-page: 3182
  ident: CR19
  article-title: Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells
  publication-title: Cancer Sci.
  doi: 10.1111/cas.14181
– volume: 92
  start-page: 435
  year: 2019
  end-page: 452
  ident: CR58
  article-title: Lipid droplets and the management of cellular stress
  publication-title: Yale J. Biol. Med.
– volume: 143
  start-page: 33
  year: 1984
  end-page: 46
  ident: CR71
  article-title: Establishment of a human pancreatic cancer cell line and detection of pancreatic cancer associated antigen
  publication-title: Tohoku J. Exp. Med.
  doi: 10.1620/tjem.143.33
– volume: 575
  start-page: 688
  year: 2019
  end-page: 692
  ident: CR12
  article-title: The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
  publication-title: Nature
  doi: 10.1038/s41586-019-1705-2
– volume: 27
  start-page: 1677
  year: 2022
  ident: CR25
  article-title: Resolvins, protectins, and maresins: DHA-derived specialized pro-resolving mediators, biosynthetic pathways, synthetic approaches, and their role in inflammation
  publication-title: Molecules
  doi: 10.3390/molecules27051677
– volume: 22
  start-page: 7524
  year: 2003
  end-page: 7536
  ident: CR52
  article-title: Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1206952
– volume: 10
  start-page: 219
  year: 2008
  end-page: 235
  ident: CR63
  article-title: Neurological benefits of omega-3 fatty acids
  publication-title: Neuromol. Med.
  doi: 10.1007/s12017-008-8036-z
– volume: 15
  start-page: 333
  year: 2018
  end-page: 348
  ident: CR51
  article-title: Therapeutic developments in pancreatic cancer: Current and future perspectives
  publication-title: Nat. Rev. Gastroenterol. Hepatol.
  doi: 10.1038/s41575-018-0005-x
– volume: 18
  start-page: 1106
  year: 2021
  end-page: 1121
  ident: CR30
  article-title: Necroptosis, pyroptosis and apoptosis: An intricate game of cell death
  publication-title: Cell Mol. Immunol.
  doi: 10.1038/s41423-020-00630-3
– volume: 288
  start-page: 7117
  year: 2013
  end-page: 7126
  ident: CR20
  article-title: Oleic acid stimulates complete oxidation of fatty acids through protein kinase A-dependent activation of SIRT1-PGC1alpha complex
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M112.415729
– volume: 13
  start-page: 91
  year: 2017
  end-page: 98
  ident: CR27
  article-title: ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.2239
– volume: 585
  start-page: 603
  year: 2020
  end-page: 608
  ident: CR39
  article-title: Plasticity of ether lipids promotes ferroptosis susceptibility and evasion
  publication-title: Nature
  doi: 10.1038/s41586-020-2732-8
– volume: 10
  start-page: 50
  year: 2012
  ident: CR64
  article-title: New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids
  publication-title: BMC Med.
  doi: 10.1186/1741-7015-10-50
– volume: 18
  start-page: 280
  year: 2021
  end-page: 296
  ident: CR36
  article-title: Broadening horizons: The role of ferroptosis in cancer
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/s41571-020-00462-0
– volume: 32
  start-page: 229
  year: 2020
  end-page: 242
  ident: CR56
  article-title: Targeting DGAT1 ameliorates glioblastoma by increasing fat catabolism and oxidative stress
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2020.06.002
– volume: 56
  start-page: 1363
  year: 2021
  end-page: 1393
  ident: CR44
  article-title: Lipid metabolism in cancer: New perspectives and emerging mechanisms
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2021.04.013
– volume: 247–265
  start-page: 2018
  year: 1863
  ident: CR57
  article-title: Lipid droplets induced by secreted phospholipase A(2) and unsaturated fatty acids protect breast cancer cells from nutrient and lipotoxic stress
  publication-title: Biochim. Biophys. Acta Mol. Cell Biol. Lipids
  doi: 10.1016/j.bbalip.2017.12.006
– volume: 136
  start-page: 4551
  year: 2014
  end-page: 4556
  ident: CR48
  article-title: Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja411006a
– volume: 547
  start-page: 453
  year: 2017
  end-page: 457
  ident: CR67
  article-title: Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
  publication-title: Nature
  doi: 10.1038/nature23007
– volume: 10
  start-page: 755
  year: 2019
  ident: CR68
  article-title: The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-019-1984-4
– volume: 10
  start-page: 1182
  year: 2020
  end-page: 1193
  ident: CR49
  article-title: Abrogation of ARF6 promotes RSL3-induced ferroptosis and mitigates gemcitabine resistance in pancreatic cancer cells
  publication-title: Am. J. Cancer Res.
– volume: 60
  start-page: 5451
  year: 2000
  end-page: 5455
  ident: CR53
  article-title: Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells
  publication-title: Cancer Res.
– volume: 369
  start-page: 1691
  year: 2013
  end-page: 1703
  ident: CR7
  article-title: Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1304369
– volume: 8
  start-page: 3046
  year: 2009
  end-page: 3055
  ident: CR35
  article-title: Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-09-0551
– volume: 17
  start-page: 801
  year: 2016
  ident: 55050_CR5
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(16)00172-8
– volume: 150
  start-page: 231
  year: 1986
  ident: 55050_CR70
  publication-title: Tohoku J. Exp. Med.
  doi: 10.1620/tjem.150.231
– volume: 45
  start-page: 1105
  year: 2017
  ident: 55050_CR24
  publication-title: Biochem. Soc. Trans.
  doi: 10.1042/BST20160474
– volume: 27
  start-page: 1677
  year: 2022
  ident: 55050_CR25
  publication-title: Molecules
  doi: 10.3390/molecules27051677
– volume: 33
  start-page: 1701
  year: 2021
  ident: 55050_CR60
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2021.05.016
– volume: 8
  start-page: 434
  year: 2022
  ident: 55050_CR41
  publication-title: Cell Death Discov.
  doi: 10.1038/s41420-022-01212-0
– volume: 32
  start-page: 229
  year: 2020
  ident: 55050_CR56
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2020.06.002
– volume: 143
  start-page: 33
  year: 1984
  ident: 55050_CR71
  publication-title: Tohoku J. Exp. Med.
  doi: 10.1620/tjem.143.33
– volume: 18
  start-page: 280
  year: 2021
  ident: 55050_CR36
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/s41571-020-00462-0
– volume: 92
  start-page: 435
  year: 2019
  ident: 55050_CR58
  publication-title: Yale J. Biol. Med.
– volume: 547
  start-page: 453
  year: 2017
  ident: 55050_CR67
  publication-title: Nature
  doi: 10.1038/nature23007
– volume: 8
  start-page: 3046
  year: 2009
  ident: 55050_CR35
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-09-0551
– volume: 136
  start-page: 4551
  year: 2014
  ident: 55050_CR48
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja411006a
– volume: 56
  start-page: 1363
  year: 2021
  ident: 55050_CR44
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2021.04.013
– volume: 11
  start-page: 1081
  year: 2015
  ident: 55050_CR43
  publication-title: Arch. Med. Sci.
  doi: 10.5114/aoms.2015.54865
– volume: 61
  start-page: 1150
  year: 2020
  ident: 55050_CR22
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.R120000800
– volume: 18
  start-page: 1106
  year: 2021
  ident: 55050_CR30
  publication-title: Cell Mol. Immunol.
  doi: 10.1038/s41423-020-00630-3
– volume: 10
  start-page: 50
  year: 2012
  ident: 55050_CR64
  publication-title: BMC Med.
  doi: 10.1186/1741-7015-10-50
– volume: 369
  start-page: 1691
  year: 2013
  ident: 55050_CR7
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1304369
– volume: 117
  start-page: 32433
  year: 2020
  ident: 55050_CR66
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.2006828117
– volume: 65
  start-page: 102840
  year: 2023
  ident: 55050_CR38
  publication-title: Redox Biol.
  doi: 10.1016/j.redox.2023.102840
– volume: 21
  start-page: 579
  year: 2019
  ident: 55050_CR40
  publication-title: Nat. Cell Biol.
  doi: 10.1038/s41556-019-0305-6
– volume: 144
  start-page: 241
  year: 2016
  ident: 55050_CR3
  publication-title: Prog. Mol. Biol. Transl. Sci.
  doi: 10.1016/bs.pmbts.2016.09.008
– volume: 13
  start-page: 91
  year: 2017
  ident: 55050_CR27
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.2239
– volume: 13
  start-page: 3
  year: 2021
  ident: 55050_CR32
  publication-title: J. Mol. Cell Biol.
  doi: 10.1093/jmcb/mjaa055
– volume: 77
  start-page: 101017
  year: 2020
  ident: 55050_CR23
  publication-title: Prog. Lipid Res.
  doi: 10.1016/j.plipres.2019.101017
– volume: 288
  start-page: 21197
  year: 2013
  ident: 55050_CR54
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M113.484576
– volume: 142
  start-page: 610S
  year: 2012
  ident: 55050_CR26
  publication-title: J. Nutr.
  doi: 10.3945/jn.111.149328
– volume: 421
  start-page: 98
  year: 2012
  ident: 55050_CR34
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2012.03.122
– volume: 247–265
  start-page: 2018
  year: 1863
  ident: 55050_CR57
  publication-title: Biochim. Biophys. Acta Mol. Cell Biol. Lipids
  doi: 10.1016/j.bbalip.2017.12.006
– volume: 13
  start-page: 81
  year: 2017
  ident: 55050_CR28
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.2238
– volume: 171
  start-page: 273
  year: 2017
  ident: 55050_CR37
  publication-title: Cell
  doi: 10.1016/j.cell.2017.09.021
– volume: 57
  start-page: 4891
  year: 2020
  ident: 55050_CR72
  publication-title: Mol. Neurobiol.
  doi: 10.1007/s12035-020-02057-3
– volume: 12
  start-page: 34
  year: 2019
  ident: 55050_CR13
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/s13045-019-0720-y
– volume: 90
  start-page: 367
  year: 2010
  ident: 55050_CR62
  publication-title: Physiol. Rev.
  doi: 10.1152/physrev.00003.2009
– volume: 10
  start-page: 1182
  year: 2020
  ident: 55050_CR49
  publication-title: Am. J. Cancer Res.
– volume: 15
  start-page: 333
  year: 2018
  ident: 55050_CR51
  publication-title: Nat. Rev. Gastroenterol. Hepatol.
  doi: 10.1038/s41575-018-0005-x
– volume: 3
  start-page: 232
  year: 2017
  ident: 55050_CR47
  publication-title: ACS Cent. Sci.
  doi: 10.1021/acscentsci.7b00028
– volume: 1441
  start-page: 4
  year: 1999
  ident: 55050_CR61
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/s1388-1981(99)00137-7
– volume: 16
  start-page: 5619
  year: 2015
  ident: 55050_CR2
  publication-title: Asian Pac. J. Cancer Prev.
  doi: 10.7314/apjcp.2015.16.14.5619
– volume: 156
  start-page: 317
  year: 2014
  ident: 55050_CR18
  publication-title: Cell
  doi: 10.1016/j.cell.2013.12.010
– volume: 93
  start-page: 4225
  year: 2007
  ident: 55050_CR46
  publication-title: Biophys. J.
  doi: 10.1529/biophysj.107.112565
– volume: 22
  start-page: 266
  year: 2021
  ident: 55050_CR10
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/s41580-020-00324-8
– volume: 42
  start-page: 5719
  year: 2022
  ident: 55050_CR14
  publication-title: Anticancer Res.
  doi: 10.21873/anticanres.16079
– volume: 38
  start-page: 479
  year: 2021
  ident: 55050_CR69
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-021-03009-9
– volume: 7
  start-page: e1000267
  year: 2010
  ident: 55050_CR4
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.1000267
– volume: 60
  start-page: 5451
  year: 2000
  ident: 55050_CR53
  publication-title: Cancer Res.
– volume: 10
  start-page: 219
  year: 2008
  ident: 55050_CR63
  publication-title: Neuromol. Med.
  doi: 10.1007/s12017-008-8036-z
– volume: 22
  start-page: 1042
  year: 2020
  ident: 55050_CR9
  publication-title: Nat. Cell Biol.
  doi: 10.1038/s41556-020-0565-1
– volume: 22
  start-page: 7524
  year: 2003
  ident: 55050_CR52
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1206952
– volume: 133
  start-page: 144
  year: 2019
  ident: 55050_CR11
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2018.09.014
– volume: 14
  start-page: 460
  year: 2023
  ident: 55050_CR31
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-023-05930-w
– volume: 91
  start-page: 104510
  year: 2023
  ident: 55050_CR42
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2023.104510
– volume: 58
  start-page: 102546
  year: 2022
  ident: 55050_CR16
  publication-title: Redox Biol.
  doi: 10.1016/j.redox.2022.102546
– volume: 2
  start-page: 89
  year: 2011
  ident: 55050_CR55
  publication-title: Int. J. Biochem. Mol. Biol.
– volume: 28
  start-page: 765
  year: 2021
  ident: 55050_CR50
  publication-title: Cell Chem. Biol.
  doi: 10.1016/j.chembiol.2021.01.006
– volume: 110
  start-page: 3173
  year: 2019
  ident: 55050_CR19
  publication-title: Cancer Sci.
  doi: 10.1111/cas.14181
– volume: 10
  start-page: 755
  year: 2019
  ident: 55050_CR68
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-019-1984-4
– volume: 290
  start-page: 1798
  year: 2023
  ident: 55050_CR59
  publication-title: FEBS J.
  doi: 10.1111/febs.16672
– volume: 388
  start-page: 73
  year: 2016
  ident: 55050_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)00141-0
– volume: 40
  start-page: e366
  issue: 365–378
  year: 2022
  ident: 55050_CR65
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2022.02.003
– year: 2022
  ident: 55050_CR15
  publication-title: Cell Death Differ.
  doi: 10.1038/s41418-022-01096-8
– volume: 551
  start-page: 247
  year: 2017
  ident: 55050_CR17
  publication-title: Nature
  doi: 10.1038/nature24297
– volume: 288
  start-page: 7117
  year: 2013
  ident: 55050_CR20
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M112.415729
– volume: 137
  start-page: 1100
  year: 2009
  ident: 55050_CR33
  publication-title: Cell
  doi: 10.1016/j.cell.2009.05.021
– volume: 482
  start-page: 419
  year: 2017
  ident: 55050_CR45
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2016.10.086
– volume: 575
  start-page: 688
  year: 2019
  ident: 55050_CR12
  publication-title: Nature
  doi: 10.1038/s41586-019-1705-2
– volume: 39
  start-page: 2125
  year: 2017
  ident: 55050_CR8
  publication-title: Clin. Ther.
  doi: 10.1016/j.clinthera.2017.08.015
– volume: 585
  start-page: 603
  year: 2020
  ident: 55050_CR39
  publication-title: Nature
  doi: 10.1038/s41586-020-2732-8
– volume: 364
  start-page: 1817
  year: 2011
  ident: 55050_CR6
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1011923
– volume: 44
  start-page: 567
  year: 2003
  ident: 55050_CR21
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.M200356-JLR200
– volume: 26
  start-page: 420
  year: 2019
  ident: 55050_CR29
  publication-title: Cell Chem. Biol.
  doi: 10.1016/j.chembiol.2018.11.016
SSID ssj0000529419
Score 2.4859004
Snippet Despite recent advances in science and medical technology, pancreatic cancer remains associated with high mortality rates due to aggressive growth and no early...
Abstract Despite recent advances in science and medical technology, pancreatic cancer remains associated with high mortality rates due to aggressive growth and...
SourceID doaj
proquest
pubmed
crossref
springer
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 4409
SubjectTerms 631/337
631/67
631/80
692/4028
Adenocarcinoma
Cell death
Cell proliferation
Chemotherapy
Drug resistance
Ferroptosis
Gemcitabine
Humanities and Social Sciences
Linoleic acid
Linolenic acid
Lipid peroxidation
Medical technology
multidisciplinary
Pancreatic cancer
Peroxidation
Phosphorylation
Poly unsaturated fatty acids
Polyunsaturated fatty acids
Science
Science (multidisciplinary)
Survival
Tumor cell lines
Tumors
α-Linolenic acid
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhUOiltE3aOi9cyK0VsR72SscmJIRASyEN5Cb0GLWBYC9r72H_fUaWd5vSNr304oM8NtLMSPMN0nwi5HgmI7jILK2DxQQlCk-V4w2Fuhah8rgwulQo_PlLc3kjr27r20dXfaUzYZkeOCvuxFVMRekbmGknFQcleZB1FMzWWoecrWPMe5RMZVZvriXTU5VMJdRJj5EqVZNxSRMor6j8JRKNhP1_Qpm_7ZCOgefiJXkxIcbyU-7pK7IF7WvyLN8hudoh11-7-9Wy7RNBJ-LGUEY7DKvS-rvQU0y40XTYBotFNx-6_q4v--V8PPwKfYkrQQaNvvTJ-ovyO2blw49dcnNx_u3skk43JVCPiGegTuioEfkw21QeI7arIj4xls-UY54D8CZI8JgLQ0gEYVaEmYhCRheYBF6JN2S77Vp4R0odhIsK81alo3R1o1Xg1ioRAYAxGwvC1lozfqIRT7dZ3JtxO1sokzVtUNNm1LSRBfmw-WaeSTSelD5NxthIJgLssQHdwkxuYf7lFgU5WJvSTLOyNwhtKiExheIFeb95jfMpbZLYFrrlKMMTp1CSeZtdYNOTpBVVN6IgH9c-8fPnfx_Q3v8Y0D55zpPzpmp6fkC2h8USDhEPDe5odP0HeJMDmw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9VAEF5qRfCleDe1SgTfdDV7S3YfpFSxFKEi6IG-LXuthUNymuRAz793Npcj4rEvedjMhmRmducbNvMNQm8qHoONxGDhDSQokTksLS1xEIL5wsHGaFOh8Pm38mzBv16Iiz00tzuaFNjtTO1SP6lFu3x_c705hgX_cSwZlx86CEKpUIxynPB2gfkddBciU5UW6vkE90eub6o4UVPtzO6pf8WngcZ_F_b859x0CEenD9DBhCPzk9HwD9FeqB-he2Nnyc1j9ON7s9ys6y7RdgKa9Hk0fb_JjbvyHYY0HAwKY6Ftm1XfdFdd3q1Xwy-xocthfxihpMtd8ok2v4Rcvf_1BC1Ov_z8fIan_gnYAQ7qsWUqKsBDxJSFgzhuiwhXiPCVtMTREGjpeXCQIQefaMMM8xWLjEfrCQ-0YE_Rft3U4TnKlWc2SshmpYrcilJJT42RLIYQCDExQ2TWmnYTuXjqcbHUwyE3k3rUtAZN60HTmmfo7XbOaqTWuFX6UzLGVjLRYg8DTXupp1WmbUFk5K4MlbJc0iA59VxE0IBQyosiQ0ezKfXsahoAT8E4JFY0Q6-3t2GVpaMTU4dmPcjQxDSUZJ6NLrB9k6QVKUqWoXezT_x5-P8_6PD2d3mB7tPklql6nh6h_b5dh5eAf3r7anDq38AM_ss
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1baxUxEA61Ivgitl66vcgKvmkwm8ue5FEPliJUBC30LeRaC2X3sLvn4fx7J9mLiFXwZR-ykyWZmWS-2clMEHqz4jHYWBksvAEHJTKHpaU1DkIwTxxsjDYlCl9-qS-u-Odrcb2H6JwLkw_t55KWeZueT4e978HQpGQwynHC1ATzB-hhKt2etHpdr5f_KilyxSs15ccQJu_p-psNyqX678OXf8RGs8k5f4qeTFix_DCO7gDtheYQPRpvj9w9Q9--tne7bdOneQBi9GU0w7Arjbv1PQZXG4QGbaHr2s3Q9rd92W83-dhr6EvYA0a46EqX5N6VN-CPDz-eo6vzT9_XF3i6IwE7wDoDtkxFBZinMjVxYKstifAEK76StnI0BFp7Hhx4wcGn0mCG-RWLjEfrKx4oYS_QftM24QiVyjMbJXisUkVuRa2kp8ZIFkMIVWVigaqZa9pNBcTTPRZ3OgeymdQjpzVwWmdOa16gt0ufzVg-45_UH5MwFspU-jo3tN2NnlRBW1LJyF0dVspySYPk1HMRgQNCKS9IgU5nUeppPfYaQA1hHJwnWqDXy2tYSSk8YprQbjMNTdWEEs3LUQWWkSSuSFGzAr2bdeLXx_8-oeP_Iz9Bj2lS05QxT0_R_tBtwxlgnsG-ykr-E3ar-Wc
  priority: 102
  providerName: Springer Nature
Title Polyunsaturated fatty acids-induced ferroptosis suppresses pancreatic cancer growth
URI https://link.springer.com/article/10.1038/s41598-024-55050-4
https://www.ncbi.nlm.nih.gov/pubmed/38388563
https://www.proquest.com/docview/2930345972
https://www.proquest.com/docview/2932017072
https://doaj.org/article/b018f4c6e79b482e842d45f31a599d50
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9wwDDdby2AvY99L1x0Z7G0zTWwncZ7G9WgpBy1lXeHeTPzVFUpyS3IP999XcnIpY1tfEnCc4Eiy9JNlS4R8KYR32qcVzWwFDornhkrNcuqyjNvEgGLUeFD4_CI_uxbLVbYaF9y6cVvlTicGRW0bg2vkR2CWEi4A_rLv698Uq0ZhdHUsofGU7GPqMtzSVayKaY0Fo1giLcezMgmXRx3YKzxTxgRFaJ5Q8Yc9Cmn7_4U1_4qTBvNz-pK8GHFjPB8Y_Yo8cfVr8myoJLl9Q64um7vtpu4wTSegRxv7qu-3cWVubUfB7QYGQptr22bdN91tF3ebddgC67oY9MEAHU1sUAba-AZ88_7XW3J9evJzcUbHegnUAO7pqealLwH_pFWeGLDbOvFwBYteSJ0a5hzLrXAGPGJnMU1YxW3BPRde21Q4lvB3ZK9uaveBxKXl2kvwXmXphc7yUlpWVZJ751yaVj4i6Y5qyozJxLGmxZ0KQW0u1UBpBZRWgdJKROTr9M56SKXxaO9jZMbUE9Ngh4amvVHjrFI6SaUXJndFqYVkTgpmReaBAllZ2iyJyOGOlWqcm516kKSIfJ4ew6zCUElVu2YT-jDMLIR93g8iMI0EqSKznEfk204mHj7-_x86eHwsH8lzhmKJp-XZIdnr2437BHin17Mg1DOyP58vr5ZwPz65uPwBrYt8MQtrCHA9F_IezpUBhA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VVgguiDeBAkGCE0RNbCfrHBCi0GpL21UFrdSb8bOtVCXbJKtq_xS_kXFeFQJ66yUHx7Gc8ed5eDwzAG8nzFnlEhmlRqKB4qiOuCJZZNOUmlgjY1Q-UHh_lk2P2Lfj9HgFfg2xMP5a5cATW0ZtSu3PyDdQLMWUofpLPs0vIl81yntXhxIaHSx27fISTbb6485XXN93hGxvHX6ZRn1VgUijdtBEiuYuRy0hkVmsUbqp2OET5d6Eq0QTa0lmmNVoN1rjk2lJaibUUeaUSZglMcVxb8Eaw1fICNY2t2YH38dTHe83Y0neR-fElG_UKCF9FBthkTcG4oj9IQHbQgH_0m7_8sy2Am_7PtzrNdXwcwetB7Bii4dwu6tduXwEPw7K8-WiqH1iUNRXTehk0yxDqc9MHaGhj5DBNltV5bwp67M6rBfz9tKtrUPkQJ2yqkPtUVeFJ1V52Zw-hqMboeUTWC3Kwj6DMDdUOY72Ms8dU2mWc0Ok5NRZa5NEugCSgWpC9-nLfRWNc9G60SkXHaUFUlq0lBYsgPfjN_Muece1vTf9Yow9feLttqGsTkS_j4WKE-6YzuwkV4wTyxkxLHVIgTTPTRoHsD4spei5QS2usBvAm_E17mPvnJGFLRdtH-JzGfk-TzsIjDPxVOFpRgP4MGDiavD__9Dz6-fyGu5MD_f3xN7ObPcF3CUeoj5Wn6zDalMt7EvUthr1qod4CD9velf9BrZ8OKs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYgL4k2gQJDgBNHGjyTOASGgrFoKVSWotDcTv9pKVbJNsqr2r_HrmMmrQkBvveSQOJYz_uaV8cwQ8ioT3mlPiyixBTgonptIapZGLkm4jQ0IRo2Jwt_2051D8WWRLDbIrzEXBo9VjjKxE9S2MviPfAZqKeYCzF8288OxiIPt-fvlWYQdpDDSOrbT6CGy59bn4L4173a3Ya9fMzb__OPTTjR0GIgMWAptpHnuc7AYaJHGBjSdjj1cQQdmUlPDnGOpFc6AD-ksFtYquM2458JrS4VjMYd5r5HrGU8o8li2yKb_OxhBEzQf8nRiLmcN6ErMZ2MiQrcgjsQfurBrGfAvO_evGG2n-uZ3yO3BZg0_9CC7SzZceY_c6LtYru-T7wfV6XpVNlgiFCxXG_qibddhYU5sE4HLD-CBe66uq2VbNSdN2KyW3fFb14Qgi3qz1YQG8VeHR3V13h4_IIdXQsmHZLOsSveYhLnl2kvwnGXuhU7SXFpWFJJ75xylhQ8IHammzFDIHPtpnKouoM6l6imtgNKqo7QSAXkzvbPsy3hcOvojbsY0Ektwdzeq-kgNHK10TKUXJnVZroVkTgpmReKBAkme2yQOyNa4lWqQC426QHFAXk6PgaMxTFOUrlp1YxhWNcIxj3oITCtBqsgk5QF5O2LiYvL_f9CTy9fygtwEXlJfd_f3npJbDBGKSftsi2y29co9A7Or1c87fIfk51Uz1G8Jrzt7
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Polyunsaturated+fatty+acids-induced+ferroptosis+suppresses+pancreatic+cancer+growth&rft.jtitle=Scientific+reports&rft.au=Suda%2C+Akane&rft.au=Umaru%2C+Banlanjo+Abdulaziz&rft.au=Yamamoto%2C+Yui&rft.au=Shima%2C+Hiroki&rft.date=2024-02-22&rft.pub=Nature+Publishing+Group&rft.eissn=2045-2322&rft.volume=14&rft.issue=1&rft.spage=4409&rft_id=info:doi/10.1038%2Fs41598-024-55050-4&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon